Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.

Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj G.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180074. doi: 10.1183/16000617.0074-2018. Print 2018 Dec 31. Review.

2.

A Man with a Decade of Persistent Pulmonary Opacities.

Maley JH, Dannheim K, Kooistra T, Hallowell RW.

Ann Am Thorac Soc. 2018 Nov;15(11):1344-1348. doi: 10.1513/AnnalsATS.201803-222CC. No abstract available.

PMID:
30382779
3.

Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis.

Shea M, Rangachari D, Hallowell RW, Hollie NI, Costa DB, VanderLaan PA.

Cancer Treat Res Commun. 2018;15:17-20. doi: 10.1016/j.ctarc.2018.02.004. Epub 2018 Feb 21.

PMID:
30207283
4.

mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis.

Hallowell RW, Collins SL, Craig JM, Zhang Y, Oh M, Illei PB, Chan-Li Y, Vigeland CL, Mitzner W, Scott AL, Powell JD, Horton MR.

Nat Commun. 2017 Jan 27;8:14208. doi: 10.1038/ncomms14208.

5.

Intravenous Immunoglobulin as Potential Adjunct Therapy for Interstitial Lung Disease.

Hallowell RW, Amariei D, Danoff SK.

Ann Am Thorac Soc. 2016 Oct;13(10):1682-1688.

PMID:
27482830
6.

Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis.

Hamblin MJ, Eberlein M, Black K, Hallowell R, Collins S, Chan-Li Y, Horton MR.

Int J Biomed Sci. 2014 Sep;10(3):146-57.

7.

Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances.

Hallowell RW, Danoff SK.

Curr Opin Rheumatol. 2014 Nov;26(6):684-9. doi: 10.1097/BOR.0000000000000104. Review.

PMID:
25203119
8.

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis.

Zhao H, Chan-Li Y, Collins SL, Zhang Y, Hallowell RW, Mitzner W, Horton MR.

BMC Pulm Med. 2014 Apr 18;14:64. doi: 10.1186/1471-2466-14-64.

9.

Pulmonary manifestations of polymyositis/dermatomyositis.

Hallowell RW, Ascherman DP, Danoff SK.

Semin Respir Crit Care Med. 2014 Apr;35(2):239-48. doi: 10.1055/s-0034-1371528. Epub 2014 Mar 25. Review.

PMID:
24668538
10.

Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.

Hallowell RW, Horton MR.

Drugs. 2014 Mar;74(4):443-50. doi: 10.1007/s40265-014-0190-z. Review.

PMID:
24570384
11.

Hyaluronan fragments induce IFN╬▓ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway.

Black KE, Collins SL, Hagan RS, Hamblin MJ, Chan-Li Y, Hallowell RW, Powell JD, Horton MR.

J Inflamm (Lond). 2013 May 30;10(1):23. doi: 10.1186/1476-9255-10-23.

12.

Revisiting thalidomide: fighting with caution against idiopathic pulmonary fibrosis.

Horton MR, Hallowell RW.

Drugs Today (Barc). 2012 Oct;48(10):661-71. doi: 10.1358/dot.2012.48.10.1855760. Review.

PMID:
23110262
13.

Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia.

Hallowell RW, Reed RM, Fraig M, Horton MR, Girgis RE.

Pulm Circ. 2012 Jan-Mar;2(1):101-6. doi: 10.4103/2045-8932.94842.

14.

Pulmonary vaccination as a novel treatment for lung fibrosis.

Collins SL, Chan-Li Y, Hallowell RW, Powell JD, Horton MR.

PLoS One. 2012;7(2):e31299. doi: 10.1371/journal.pone.0031299. Epub 2012 Feb 17.

Supplemental Content

Loading ...
Support Center